List of Excipients in Branded Drug PENICILLIN G POTASSIUM

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Baxter Healthcare Corporation	PENICILLIN G POTASSIUM	penicillin g	0338-1025	DEXTROSE MONOHYDRATE
Baxter Healthcare Corporation	PENICILLIN G POTASSIUM	penicillin g	0338-1025	HYDROCHLORIC ACID
Baxter Healthcare Corporation	PENICILLIN G POTASSIUM	penicillin g	0338-1025	SODIUM HYDROXIDE

Generic Drugs Containing PENICILLIN G POTASSIUM

Company	Ingredient	NDC	Excipient
Sandoz Inc	penicillin g potassium	0781-6135	CITRIC ACID MONOHYDRATE
Sandoz Inc	penicillin g potassium	0781-6135	SODIUM CITRATE
Sagent Pharmaceuticals	penicillin g potassium	25021-153	SODIUM CITRATE

What are the Most Frequently-Used Excipients in PENICILLIN G POTASSIUM?

# Of NDCs	Excipient
1	CITRIC ACID MONOHYDRATE
5	SODIUM CITRATE

Excipient Strategy and Commercial Opportunities for Penicillin G Potassium

Last updated: February 26, 2026

What is Penicillin G Potassium’s Formulation Strategy?

Penicillin G potassium is a narrow-spectrum beta-lactam antibiotic used to treat bacterial infections. Its formulation typically involves either intravenous (IV) or intramuscular (IM) delivery routes. The current formulations include dry powder for reconstitution, with excipients primarily serving as stabilizers, buffers, and solubilizers.

Key Excipients in Penicillin G Potassium

• Sodium carbonate/bicarbonate: Buffers that maintain pH stability.
• Mannitol and sodium chloride: Stabilizers and tonicity adjusters.
• Diluent for reconstitution: Water for injection or sterile saline.

Formulation Challenges

• Hydrolytic instability: Penicillin G degrades rapidly in aqueous solutions, requiring stabilizing excipients that expand shelf life.
• pH sensitivity: Proper buffering agents maintain activity and reduce degradation.
• Solubility: Excipients influence solubility, affecting bioavailability and preservative efficacy.

Strategy Implications

The focus is on developing formulations that extend shelf life and improve stability without compromising bioavailability. Incorporation of novel excipients like cyclodextrins or lyophilization techniques can enhance stability profiles, opening new formulation avenues.

Current Market Dynamics and Opportunities

Market Size and Growth

The global penicillin market, estimated at USD 6.4 billion in 2022, is driven by infections like pneumonia, syphilis, and bacterial endocarditis. Penicillin G represents a significant segment, especially in hospitals.

Patent and Generic Landscape

Patent protections generally expired in the late 20th century, prompting widespread generic production. Commercial opportunities now focus on formulation innovations and specialty delivery forms.

Opportunities for Excipient Innovation

• Enhanced stability formulations: Use of excipients such as cyclodextrins can improve shelf life, especially in regions with limited cold-chain logistics.

• Alternative delivery methods: Developing sustained-release or oral formulations with novel excipients could expand market access.

• Cost reduction: Using excipients that enable simplified manufacturing processes or reduce raw material costs offers advantages in price-sensitive markets.

Regulatory Considerations

FDA and EMA guidelines require demonstration of excipient safety and compatibility. Novel excipients face rigorous evaluation, potentially delaying time to market but offering differentiation once approved.

Commercial Opportunities Outlined

Opportunity Area	Description	Potential Benefits
Lyophilized formulations	Use of stabilizers and cryoprotectants to extend shelf life	Market differentiation, longer shelf life
Novel excipients (cyclodextrins, polymers)	Improve solubility, stability, and bioavailability	Competitive advantage, patentability
Orally disintegrating and sustained-release forms	Reformulating with excipient technology for new delivery modes	Access to outpatient market, patient compliance
Cost-effective excipients	Reduce manufacturing expenses	Lower pricing, higher margins

Strategic Considerations

• Patent landscape: Exploiting formulation patents can delay generic competition.
• Regulatory pathway: Compatibility with existing clinical data expedites approval.
• Partnership opportunities: Collaborations with excipient developers can accelerate innovation.

Key Takeaways

• Excipient choices critically impact stability, shelf life, and delivery forms of Penicillin G potassium.
• Opportunities exist to develop formulations with improved stability and alternative delivery methods using novel excipients.
• Regulatory requirements favor excipients with established safety profiles; innovation requires demonstrating compatibility.
• Market expansion through reformulation targeting outpatient use and cost reduction remains viable.

FAQs

1. What excipients are commonly used in Penicillin G potassium formulations?
Buffers like sodium carbonate, stabilizers such as mannitol, and diluents for reconstitution serve as common excipients.

2. How can excipient innovation extend Penicillin G potassium shelf life?
Using stabilizers like cyclodextrins or lyophilization techniques minimizes hydrolytic degradation, extending shelf life.

3. Are there opportunities for oral formulations of Penicillin G?
Yes, with appropriate excipients improving solubility and stability, oral formulations could expand use outside hospital settings.

4. What are regulatory considerations for novel excipients?
Novel excipients require safety data and compatibility studies, which can delay approval but can be a source of differentiation.

5. How can formulators reduce manufacturing costs for Penicillin G?
Utilizing cost-effective excipients that simplify manufacturing processes or improve stability can lower costs and improve margins.

---

References

1. European Medicines Agency. (2022). Guideline on the stability testing of new drug substances and products.
2. U.S. Food and Drug Administration. (2021). Guidance for Industry: Quality Considerations for Continuous Manufacturing.
3. MarketWatch. (2022). Penicillin Market Size, Share & Trends Analysis, Forecasts till 2028.
4. PubChem. (2022). Penicillin G: Chemical properties and stability information.
5. Pharmaceutical Technology. (2020). Advances in formulation strategies for beta-lactam antibiotics.